Rezultati pretraživanja
  1. prije 16 sati

    Enrolment of the VasQ external support US pivotal study now complete

  2. 4. velj

    : BD announced long-term safety data for BTK drug-coated balloon

  3. 3. velj

    Centralisation of aortic surgery is “imperative”

  4. 3. velj

    : Positive new data for AV access interventions released

  5. 3. velj

    Intact Vascular expands Tack Endovascular System portfolio offering

  6. 3. velj

    : Profusa Lumee oxygen platform may improve the clinical management of patients with CLI

  7. 3. velj

    : High- and low-dose paclitaxel-coated balloons exhibit comparable results at one-year in COMPARE-RCT

  8. 3. velj

    : Four-year ILLUMENATE data reaffirm safety profile of Stellarex

  9. 3. velj

    announces sotatercept achieved primary and secondary endpoints in the PULSAR trial

  10. 14. sij

    German claims data report higher long-term and amputation-free survival in CLTI patients treated with paclitaxel devices

  11. 9. sij

    Core outcome sets developed in UK for patients undergoing lower limb amputation

  12. 16. pro 2019.

    Enrolment complete for VALUE, the prospective EU VasQ external support postmarket study

  13. 17. tra 2019.

    Do you want to attend a BTK live case with Prof. Thomas Zeller and system? We are glad to invite you today 17th April at 14:30 in Lower Main Auditorium

  14. 16. tra 2019.

    Do you want to have a demonstration of the device? Come and visit us at the workshop

  15. 9. tra 2019.

    SAVE THE DATE! 15-18 April, 2019. We will be presenting at Charing Cross 2019. Please find enclosed our activity programe. See you in London!

  16. Mortality from rAAA decreases, but 43% occur in people not qualified for screening. Read more in .

  17. Each year approximately 200,000 people in the U.S. are diagnosed with abdominal aortic aneurysm

  18. 11. pro 2018.
  19. 26. srp 2018.
  20. 21. srp 2018.

    A number of positions are available at the conference. You will support the conference and have the opportunity to meet and learn from professionals. Apply here:

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.